Utreglutide Shows Significant Weight and Liver-Fat Reduction in Early Trials : Sun Pharma
Sun Pharmaceutical Industries Ltd. has announced new clinical findings for its investigational once-weekly GLP-1 receptor agonist, Utreglutide (GL0034), at ObesityWeek® 2025, held between November 4–7 in Atlanta, USA.






















